WNT10A variants: following the pattern of inheritance in tooth agenesis and self-reported family history of cancer

Clinical Oral Investigations - The aim of this study was the analysis of WNT10A variants in seven families of probands with various forms of tooth agenesis and self-reported family history of...     

Venous thromboembolism after lower limb arthroplasty: is chemical prophylaxis still needed?

Background

Venous thromboembolism (VTE) is a significant complication of lower limb arthroplasty. The National Institute for Health and Care Excellence recommends routine use of chemical and mechanical prophylaxis to prevent VTE. Our high-volume, elective, arthroplasty unit adopted this guidance in 2008.

Purpose

We examined our incidence of VTE before and after introduction of chemical thromboprophylaxis to determine whether the incidence of VTE reduced.

Methods

We retrospectively gathered data on 2 cohorts of patients—from January 2004 to August 2007 (Group 1) and January 2010 to December 2012 (Group 2). Patients in Group 1 received mechanical prophylaxis only (unless particularly high risk for VTE), and patients in Group 2 received mechanical and chemical prophylaxis. We recorded VTE occurring within 6 months of surgery. Patients in Group 1 receiving chemical prophylaxis were excluded.

Results

Group 1 had 2320 cases of primary and revision lower limb arthroplasty, and Group 2 had 1430 cases. VTE occurred in 37 cases in Group 1 (1.6 %), and in 17 cases in Group 2 (1.2 %). This difference was not statistically significant (p = 0.26). In Group 1, 1 patient died within 6 months due to pulmonary embolism (0.04 %); there were no VTE-related deaths in Group 2 (0 %). This was also not statistically significant (p = 0.06).

Conclusions

Although our VTE rate reduced by 0.4 % and our VTE-related mortality reduced by 0.04 % after introduction of chemical thromboprophylaxis, these differences were not statistically significant. Chemical thromboprophylaxis may not be required in all patients undergoing arthroplasty providing appropriate mechanical prophylaxis is used.

     

Management of Port‐A‐Cath Devices In Long‐Term Acute Care Hospitals

A reliable means of maintaining an intravascular access device (IVAD) is an important aspect of care for a patient in a long‐term acute care (LTAC) setting. Overall, various authors have confirmed that complication rates are lower with use of an IVAD. The key to this success in low complication rates appears to be a team approach to catheter care and management. In our unique practice setting, LTAC, we have over 20 years of experience with IVAD care and management. In an extensive 15‐year retrospective review of the IVAD care, we found very low rates of complications, including infections. This is directly related to a team approach to catheter care, protocol development, employee education, and postoperative management.     

An innovative method of fracture reduction in an arthroscopically assisted cannulated screw fixation of an Ideberg type III glenoid fracture

Significantly displaced intra-articular glenoid fractures treated nonoperatively have been found to have poor functional outcomes. For this reason, most are treated with open reduction and internal fixation. Conventional open techniques involve extensive exposure and soft tissue dissection. Moreover, visualization of the fracture and its reduction can also be difficult even with standard open techniques. We present a case of an Ideberg type III glenoid fracture treated with an arthroscopically assisted percutaneous screw fixation, using the coracoid as a reduction aide. This reduction technique is not previously reported in the literature. Arthroscopically assisted percutaneous glenoid fixation has showed promising early results in the literature. In our case, the fracture united and the patient returned to all his normal daily activities by 7 weeks postoperatively. This suggests arthroscopically assisted glenoid fixation provides good functional and radiological outcomes, without the need for extensive soft tissue dissection.     

A screen of a large Czech cohort of oligodontia patients implicates a novel mutation in the PAX9 gene

Tooth agenesis is one of the most common developmental anomalies in humans. To date, many mutations involving paired box 9 (PAX9), msh homeobox 1 (MSX1), and axin 2 (AXIN2) genes have been identified. The aim of the present study was to perform screening for mutations and/or polymorphisms using the capillary sequencing method in the critical regions of PAX9 and MSX1 genes in a group of 270 individuals with tooth agenesis and in 30 healthy subjects of Czech origin. This screening revealed a previously unknown heterozygous g.9527G>T mutation in the PAX9 gene in monozygotic twins with oligodontia and three additional affected family members. The same variant was not found in healthy relatives. This mutation is located in intron 2, in the region recognized as the splice site between exon 2 and intron 2. We hypothesize that the error in pre‐mRNA splicing may lead to lower expression of PAX9 protein and could have contributed to the development of tooth agenesis in the affected subjects.     

Unilateral metastases in the lower limb as a first presentation of prostatic carcinoma

Like most other solid malignancies, prostate cancer can metastasize to distant organs, it has an unusually high propensity for metastasizing to the bone. It prefers the axial skeleton and takes a significant toll on the male population in both morbidity and mortality. In some rare cases presentation of prostate cancer can differ.